Roles of prostanoids in the pathogenesis of cardiovascular diseases.
Roles of prostanoids in the pathogenesis of cardiovascular diseases.
复制标题
DOI:
--
复制
发表时间:
2010-04
期刊:
影响因子:
--
通讯作者:
Koh-ichi Yuhki;H. Kashiwagi;Fumiaki Kojima;J. Kawabe;F. Ushikubi
中科院分区:
文献类型:
--
作者:
Koh-ichi Yuhki;H. Kashiwagi;Fumiaki Kojima;J. Kawabe;F. Ushikubi
The roles of prostanoids in the pathogenesis of cardiovascular diseases and in the development of pathological conditions have been examined using mice lacking the individual, specific prostanoid receptor. Prostaglandin (PG) I2 protected the heart from ischemia-reperfusion injury in a model of acute myocardial infarction. In addition, PGI2 suppressed the development of pressure overload-induced cardiac hypertrophy. Aside from its potent vasodilatory action, PGI2 contributed critically to the development of renovascular hypertension via the activation of the renin-angiotensin-aldosterone system. Thromboxane (TX) A2 and PGF2alpha were found to be the mediators of inflammatory tachycardia under a systemic inflammatory condition induced by lipopolysaccharide. Under a septic condition leading to a vascular hypo-responsive state, TXA2 worked to maintain vascular tone by inhibiting the induction of inducible nitric oxide synthase in vascular smooth muscle cells. Mice lacking the PGE2 receptor subtype EP3 had a bleeding tendency and were resistant to thromboembolism, due to a defective activation of platelets. From these studies, the important and novel roles of prostanoids in the pathogenesis of cardiovascular diseases have been clarified.